NM_198904.4:c.529C>T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_198904.4(GABRG2):c.529C>T(p.Arg177*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,264 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_198904.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 74Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- febrile seizures, familial, 8Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- generalized epilepsy with febrile seizures plusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- self-limited epilepsy with centrotemporal spikesInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GABRG2 | NM_198904.4 | c.529C>T | p.Arg177* | stop_gained | Exon 4 of 10 | ENST00000639213.2 | NP_944494.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GABRG2 | ENST00000639213.2 | c.529C>T | p.Arg177* | stop_gained | Exon 4 of 10 | 1 | NM_198904.4 | ENSP00000491909.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461264Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726958 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2;C1969810:Febrile seizures, familial, 8 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg177*) in the GABRG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GABRG2 are known to be pathogenic (PMID: 22539854, 22750526, 24407264). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of GABRG2-related conditions (PMID: 29778030). ClinVar contains an entry for this variant (Variation ID: 934755). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Developmental and epileptic encephalopathy, 74 Pathogenic:1
ACMG classification criteria: PVS1 very strong, PS4 supporting, PM2 moderated
not provided Pathogenic:1
Reported previously as a predicted deleterious variant in a child with intractable epilepsy (Hesse et al., 2018).; Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24407264, 23720301, 22750526, 22539854, 29778030, 35701389, 35627257)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at